Found: 147
Select item for more details and to access through your institution.
A phase 1 study of oral ASP5878, a selective small-molecule inhibitor of fibroblast growth factor receptors 1–4, as a single dose and multiple doses in patients with solid malignancies.
- Published in:
- Investigational New Drugs, 2020, v. 38, n. 2, p. 445, doi. 10.1007/s10637-019-00780-w
- By:
- Publication type:
- Article
Efficacy and safety of lanreotide in Korean patients with metastatic, well-differentiated gastroenteropancreatic-neuroendocrine tumors: a retrospective analysis.
- Published in:
- Investigational New Drugs, 2019, v. 37, n. 4, p. 763, doi. 10.1007/s10637-018-0710-x
- By:
- Publication type:
- Article
Multicenter retrospective analysis of the safety and efficacy of regorafenib after progression on sorafenib in Korean patients with hepatocellular carcinoma.
- Published in:
- Investigational New Drugs, 2019, v. 37, n. 3, p. 567, doi. 10.1007/s10637-018-0707-5
- By:
- Publication type:
- Article
Prognostic factors in patients with metastatic or recurrent pancreatic cancer treated with first-line nab-paclitaxel plus gemcitabine: implication of inflammation-based scores.
- Published in:
- Investigational New Drugs, 2019, v. 37, n. 3, p. 584, doi. 10.1007/s10637-018-0681-y
- By:
- Publication type:
- Article
Phase I/II study of first-line combination therapy with sorafenib plus resminostat, an oral HDAC inhibitor, versus sorafenib monotherapy for advanced hepatocellular carcinoma in east Asian patients.
- Published in:
- Investigational New Drugs, 2018, v. 36, n. 6, p. 1072, doi. 10.1007/s10637-018-0658-x
- By:
- Publication type:
- Article
Nab-paclitaxel plus gemcitabine versus FOLFIRINOX as the first-line chemotherapy for patients with metastatic pancreatic cancer: retrospective analysis.
- Published in:
- Investigational New Drugs, 2018, v. 36, n. 4, p. 732, doi. 10.1007/s10637-018-0598-5
- By:
- Publication type:
- Article
Germline <italic>BRCA</italic> mutations in Asian patients with pancreatic adenocarcinoma: a prospective study evaluating risk category for genetic testing.
- Published in:
- Investigational New Drugs, 2018, v. 36, n. 1, p. 163, doi. 10.1007/s10637-017-0497-1
- By:
- Publication type:
- Article
Phase I and pharmacodynamic study of vorinostat combined with capecitabine and cisplatin as first-line chemotherapy in advanced gastric cancer.
- Published in:
- Investigational New Drugs, 2014, v. 32, n. 2, p. 271, doi. 10.1007/s10637-013-9983-2
- By:
- Publication type:
- Article
A phase II trial of a selective c-Met inhibitor tivantinib (ARQ 197) monotherapy as a second- or third-line therapy in the patients with metastatic gastric cancer.
- Published in:
- Investigational New Drugs, 2014, v. 32, n. 2, p. 355, doi. 10.1007/s10637-013-0057-2
- By:
- Publication type:
- Article
Efficacy, safety, and pharmacokinetics of imatinib dose escalation to 800 mg/day in patients with advanced gastrointestinal stromal tumors.
- Published in:
- 2013
- By:
- Publication type:
- Report
Changes in imatinib plasma trough level during long-term treatment of patients with advanced gastrointestinal stromal tumors: correlation between changes in covariates and imatinib exposure.
- Published in:
- 2012
- By:
- Publication type:
- Report
Sunitinib as a second-line therapy for advanced GISTs after failure of imatinib: relationship between efficacy and tumor genotype in Korean patients.
- Published in:
- Investigational New Drugs, 2012, v. 30, n. 2, p. 819, doi. 10.1007/s10637-010-9593-1
- By:
- Publication type:
- Article
A prospective phase II study of cetuximab in combination with XELOX (capecitabine and oxaliplatin) in patients with metastatic and/or recurrent advanced gastric cancer.
- Published in:
- Investigational New Drugs, 2011, v. 29, n. 2, p. 366, doi. 10.1007/s10637-009-9363-0
- By:
- Publication type:
- Article
The dosing frequency of sustained-release opioids and the prevalence of end-of-dose failure in cancer pain control: a Korean multicenter study.
- Published in:
- Supportive Care in Cancer, 2011, v. 19, n. 2, p. 297, doi. 10.1007/s00520-010-0825-x
- By:
- Publication type:
- Article
The dosing frequency of sustained-release opioids and the prevalence of end-of-dose failure in cancer pain control: a Korean multicenter study.
- Published in:
- 2010
- By:
- Publication type:
- journal article
Multiparametric MRI for prediction of treatment response to neoadjuvant FOLFIRINOX therapy in borderline resectable or locally advanced pancreatic cancer.
- Published in:
- European Radiology, 2021, v. 31, n. 2, p. 864, doi. 10.1007/s00330-020-07134-8
- By:
- Publication type:
- Article
Consideration of aggressive therapeutic strategies for primary testicular lymphoma.
- Published in:
- American Journal of Hematology, 2007, v. 82, n. 9, p. 840, doi. 10.1002/ajh.20973
- By:
- Publication type:
- Article
Nongastric marginal zone B-cell lymphoma: Analysis of 247 cases.
- Published in:
- American Journal of Hematology, 2007, v. 82, n. 6, p. 446, doi. 10.1002/ajh.20874
- By:
- Publication type:
- Article
Role of the prognostic nutritional index in predicting survival in advanced hepatocellular carcinoma treated with regorafenib.
- Published in:
- Hepatology Research, 2021, v. 51, n. 7, p. 796, doi. 10.1111/hepr.13669
- By:
- Publication type:
- Article
Outcomes Based on Plasma Biomarkers for the Phase 3 CELESTIAL Trial of Cabozantinib versus Placebo in Advanced Hepatocellular Carcinoma.
- Published in:
- Liver Cancer (2235-1795), 2022, v. 11, n. 1, p. 38, doi. 10.1159/000519867
- By:
- Publication type:
- Article
Pembrolizumab as Second-Line Therapy for Advanced Hepatocellular Carcinoma: A Subgroup Analysis of Asian Patients in the Phase 3 KEYNOTE-240 Trial.
- Published in:
- Liver Cancer (2235-1795), 2021, v. 10, n. 3, p. 275, doi. 10.1159/000515553
- By:
- Publication type:
- Article
Clinical Outcomes with Multikinase Inhibitors after Progression on First-Line Atezolizumab plus Bevacizumab in Patients with Advanced Hepatocellular Carcinoma: A Multinational Multicenter Retrospective Study.
- Published in:
- Liver Cancer (2235-1795), 2021, v. 10, n. 2, p. 107, doi. 10.1159/000512781
- By:
- Publication type:
- Article
Real-World Efficacy and Safety of Lenvatinib in Korean Patients with Advanced Hepatocellular Carcinoma: A Multicenter Retrospective Analysis.
- Published in:
- Liver Cancer (2235-1795), 2020, v. 9, n. 5, p. 613, doi. 10.1159/000508901
- By:
- Publication type:
- Article
Phase 1/2a Study of Rivoceranib, a Selective VEGFR-2 Angiogenesis Inhibitor, in Patients with Advanced Solid Tumors.
- Published in:
- Cancer Research & Treatment, 2024, v. 56, n. 3, p. 743, doi. 10.4143/crt.2023.980
- By:
- Publication type:
- Article
Analysis of Plasma Circulating Tumor DNA in Borderline Resectable Pancreatic Cancer Treated with Neoadjuvant Modified FOLFIRINOX: Clinical Relevance of DNA Damage Repair Gene Alteration Detection.
- Published in:
- Cancer Research & Treatment, 2023, v. 55, n. 4, p. 1313, doi. 10.4143/crt.2023.452
- By:
- Publication type:
- Article
Survival Benefit of Adjuvant Chemotherapy in Patients with Pancreatic Ductal Adenocarcinoma Who Underwent Surgery Following Neoadjuvant FOLFIRINOX.
- Published in:
- Cancer Research & Treatment, 2023, v. 55, n. 3, p. 956, doi. 10.4143/crt.2022.409
- By:
- Publication type:
- Article
Adjuvant Chemotherapy for Resected Ampulla of Vater Carcinoma: Retrospective Analysis of 646 Patients.
- Published in:
- Cancer Research & Treatment, 2021, v. 53, n. 2, p. 424, doi. 10.4143/crt.2020.953
- By:
- Publication type:
- Article
Systemic Treatment of Advanced Gastroenteropancreatic Neuroendocrine Tumors in Korea: Literature Review and Expert Opinion.
- Published in:
- Cancer Research & Treatment, 2021, v. 53, n. 2, p. 291, doi. 10.4143/crt.2020.1233
- By:
- Publication type:
- Article
Spatial Distribution and Prognostic Implications of Tumor-Infiltrating FoxPS<sup>-</sup> CD4<sup>+</sup> T Cells in Biliary Tract Cancer.
- Published in:
- Cancer Research & Treatment, 2021, v. 53, n. 1, p. 162, doi. 10.4143/crt.2020.704
- By:
- Publication type:
- Article
Efficacy and Safety of Pembrolizumab in Patients with Refractory Advanced Biliary Tract Cancer: Tumor Proportion Score as a Potential Biomarker for Response.
- Published in:
- Cancer Research & Treatment, 2020, v. 52, n. 2, p. 594, doi. 10.4143/crt.2019.493
- By:
- Publication type:
- Article
Clinical Outcomes of Second-Line Chemotherapy after Progression on Nab-Paclitaxel Plus Gemcitabine in Patients with Metastatic Pancreatic Adenocarcinoma.
- Published in:
- Cancer Research & Treatment, 2020, v. 52, n. 1, p. 254, doi. 10.4143/crt.2019.190
- By:
- Publication type:
- Article
Clinical Benefit of Maintenance Therapy for Advanced Biliary Tract Cancer Patients Showing No Progression after First-Line Gemcitabine Plus Cisplatin.
- Published in:
- Cancer Research & Treatment, 2019, v. 51, n. 3, p. 901, doi. 10.4143/crt.2018.326
- By:
- Publication type:
- Article
Phase I Dose-Finding Study of OPB-111077, a Novel STAT3 Inhibitor, in Patients with Advanced Hepatocellular Carcinoma.
- Published in:
- Cancer Research & Treatment, 2019, v. 51, n. 2, p. 510, doi. 10.4143/crt.2018.226
- By:
- Publication type:
- Article
Multicenter Phase II Study of Oxaliplatin, Irinotecan, and S-1 as First-Line Treatment for Patients with Recurrent or Metastatic Biliary Tract Cancer.
- Published in:
- Cancer Research & Treatment, 2018, v. 50, n. 4, p. 1324, doi. 10.4143/crt.2017.526
- By:
- Publication type:
- Article
Prognosis of Pancreatic Cancer Patients with Synchronous or Metachronous Malignancies from Other Organs Is Better than Those with Pancreatic Cancer Only.
- Published in:
- Cancer Research & Treatment, 2018, v. 50, n. 4, p. 1175, doi. 10.4143/crt.2017.494
- By:
- Publication type:
- Article
Efficacy and Safety of Regorafenib in Korean Patients with Advanced Gastrointestinal Stromal Tumor after Failure of Imatinib and Sunitinib: A Multicenter Study Based on the Management Access Program.
- Published in:
- Cancer Research & Treatment, 2017, v. 49, n. 2, p. 350, doi. 10.4143/crt.2016.067
- By:
- Publication type:
- Article
Real-Life Experience of Sorafenib Treatment for Hepatocellular Carcinoma in Korea: From GIDEON Data.
- Published in:
- Cancer Research & Treatment, 2016, v. 48, n. 4, p. 1243, doi. 10.4143/crt.2015.278
- By:
- Publication type:
- Article
Efficacy of Imatinib in Patients with Platelet-Derived Growth Factor Receptor Alpha-Mutated Gastrointestinal Stromal Tumors.
- Published in:
- Cancer Research & Treatment, 2016, v. 48, n. 2, p. 546, doi. 10.4143/crt.2015.015
- By:
- Publication type:
- Article
Severe Imatinib-Associated Skin Rash in Gastrointestinal Stromal Tumor Patients: Management and Clinical Implications.
- Published in:
- Cancer Research & Treatment, 2016, v. 48, n. 1, p. 162, doi. 10.4143/crt.2015.017
- By:
- Publication type:
- Article
Correction to: Efficacy and Safety Results from a Phase 2, Randomized, Double Blind Study of Enzalutamide Versus Placebo in Advanced Hepatocellular Carcinoma.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Efficacy and Safety Results from a Phase 2, Randomized, Double-Blind Study of Enzalutamide Versus Placebo in Advanced Hepatocellular Carcinoma.
- Published in:
- Clinical Drug Investigation, 2021, v. 41, n. 9, p. 795, doi. 10.1007/s40261-021-01063-0
- By:
- Publication type:
- Article
A Prospective Randomized Comparison of a Covered Metallic Ureteral Stent and a Double-J Stent for Malignant Ureteral Obstruction.
- Published in:
- Korean Journal of Radiology, 2018, v. 19, n. 4, p. 606, doi. 10.3348/kjr.2018.19.4.606
- By:
- Publication type:
- Article
Kinetics of the neutrophil‐lymphocyte ratio during PD‐1 inhibition as a prognostic factor in advanced hepatocellular carcinoma.
- Published in:
- Liver International, 2021, v. 41, n. 9, p. 2189, doi. 10.1111/liv.14932
- By:
- Publication type:
- Article
Clinical outcomes of systemic therapy in patients with unresectable or metastatic combined hepatocellular‐cholangiocarcinoma.
- Published in:
- Liver International, 2021, v. 41, n. 6, p. 1398, doi. 10.1111/liv.14813
- By:
- Publication type:
- Article
Regorafenib in patients with advanced Child‐Pugh B hepatocellular carcinoma: A multicentre retrospective study.
- Published in:
- Liver International, 2020, v. 40, n. 10, p. 2544, doi. 10.1111/liv.14573
- By:
- Publication type:
- Article
Regorafenib in previously treated advanced hepatocellular carcinoma: Impact of prior immunotherapy and adverse events.
- Published in:
- Liver International, 2020, v. 40, n. 9, p. 2263, doi. 10.1111/liv.14496
- By:
- Publication type:
- Article
Real-world efficacy and safety of cabozantinib in Korean patients with advanced hepatocellular carcinoma: a multicenter retrospective analysis.
- Published in:
- Therapeutic Advances in Medical Oncology, 2022, p. 1, doi. 10.1177/17588359221097934
- By:
- Publication type:
- Article
Real-world outcomes of adjuvant gemcitabine versus gemcitabine plus capecitabine for resected pancreatic ductal adenocarcinoma.
- Published in:
- Therapeutic Advances in Medical Oncology, 2022, p. 1, doi. 10.1177/17588359221097190
- By:
- Publication type:
- Article
ALBI score and outcomes in patients with hepatocellular carcinoma: post hoc analysis of the randomized controlled trial KEYNOTE-240.
- Published in:
- Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/17588359211039928
- By:
- Publication type:
- Article
Clinical outcomes of liposomal irinotecan plus fluorouracil/leucovorin for metastatic pancreatic adenocarcinoma in patients previously treated with conventional irinotecan-containing chemotherapy.
- Published in:
- Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/17588359211003053
- By:
- Publication type:
- Article